Engineered Extracellular Vesicles in Glioma Therapy: Recent Advances and Applications.

Area of Science:

• Neuro-oncology
• Biotechnology
• Drug Delivery Systems

Background:

• Gliomas are complex central nervous system tumors with a challenging microenvironment that limits chemotherapy efficacy.
• The blood-brain barrier restricts drug penetration, necessitating novel therapeutic strategies.
• Extracellular vesicles (EVs) are natural carriers with potential for drug delivery but require modification for clinical application.

Purpose of the Study:

• To review extracellular vesicle (EV) characteristics and isolation methods.
• To highlight engineering strategies for enhancing EV-based glioma therapy.
• To summarize progress and challenges in translating engineered EVs for clinical use.

Main Methods:

• Review of existing literature on EV biology, engineering, and applications in glioma.
• Analysis of EV isolation techniques and their suitability for therapeutic development.
• Examination of engineering approaches to improve EV targeting, payload, and production.

Main Results:

• Engineered EVs offer improved tissue targeting, drug payload capacity, and controlled cargo compared to unmodified EVs.
• Recent advancements demonstrate the potential of engineered EVs in preclinical glioma models.
• Key challenges remain in manufacturing yield, scalability, and clinical validation.

Conclusions:

• Engineered extracellular vesicles represent a promising platform for advanced glioma therapy.
• Overcoming current limitations in EV engineering and manufacturing is crucial for clinical translation.
• Further research and development are essential to realize the full therapeutic potential of engineered EVs in neuro-oncology.